Haemophilia, hepatitis and porphyria

Authors

  • J.W. BURNETT,

    Corresponding author
    1. Division of Dermatology, University of Maryland School of Medicine, Baltimore, MD 21201; †Metabolism Branch, National Cancer Institute, Bethesda, MD 20014, ‡Hematology Division, Department of Medicine, The Johns Hopkins University School of Medicine and Hospital, Baltimore, MD 21205, U.S.A.
      Reprints requests to: Dr Joseph W.Burnett, Dermatology, University of Md. Hospital, Baltimore, Maryland 2I20I, U.S.A.
    Search for more papers by this author
  • J.M. LAMON,

    1. Division of Dermatology, University of Maryland School of Medicine, Baltimore, MD 21201; †Metabolism Branch, National Cancer Institute, Bethesda, MD 20014, ‡Hematology Division, Department of Medicine, The Johns Hopkins University School of Medicine and Hospital, Baltimore, MD 21205, U.S.A.
    Search for more papers by this author
  • J. LEVIN

    1. Division of Dermatology, University of Maryland School of Medicine, Baltimore, MD 21201; †Metabolism Branch, National Cancer Institute, Bethesda, MD 20014, ‡Hematology Division, Department of Medicine, The Johns Hopkins University School of Medicine and Hospital, Baltimore, MD 21205, U.S.A.
    Search for more papers by this author

  • Supported in part by Research Grant HL 01601 from the National Heart and Lung Institute, NIH, Bethesda, MD.

Reprints requests to: Dr Joseph W.Burnett, Dermatology, University of Md. Hospital, Baltimore, Maryland 2I20I, U.S.A.

No abstract is available for this article.

Ancillary